Apr 20, 2024
Version 2
Small molecules released from islets of Langerhans determined by liquid chromatography – mass spectrometry V.2
- Emmanuel O. Ogunkunle1,
- Matthew J. Donohue1,
- Daniel J. Steyer1,
- Damilola I. Adeoye1,
- Wesley J. Eaton1,
- Michael Roper1
- 1Department of Chemistry and Biochemistry, Florida State University, 95 Chieftain Way, Tallahassee, FL 32306, USA
Protocol Citation: Emmanuel O. Ogunkunle, Matthew J. Donohue, Daniel J. Steyer, Damilola I. Adeoye, Wesley J. Eaton, Michael Roper 2024. Small molecules released from islets of Langerhans determined by liquid chromatography – mass spectrometry. protocols.io https://dx.doi.org/10.17504/protocols.io.6qpvr6rnzvmk/v2Version created by Sandy Beshir
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 20, 2024
Last Modified: April 20, 2024
Protocol Integer ID: 98520
Keywords: Small molecules, Langerhan, liquid chromatography, mass spectrometry, islet
Funders Acknowledgement:
NIH
Grant ID: UC4 DK116283
Abstract
Islets of Langerhans are the endocrine tissue within the pancreas that secrete hormones for maintenance of blood glucose homeostasis. A variety of small molecules including classical neurotransmitters are also released from islets. While the roles of most of these small molecules are unknown, some have been hypothesized to play a critical role in islet physiology. To better understand their role on islet function, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to separate and quantify 39 small molecules released from islets. Benzoyl chloride derivatization of analyte molecules was used to impart retention and facilitate electrospray ionization efficiency. Separation was achieved on a 2.1 × 150 mm column packed with 2.7 μm core–shell C18particles. Calibration curves showed excellent linearity between the concentration and analyte response, with relative standard deviations of the analyte responses below 15% and limits of detection from 0.01–40 nM. The method was applied to examine small molecules released from murine and human islets of Langerhans after static incubation and perfusion with glucose. Results showed a decrease in secretion rates with increasing glucose concentration for most of the analytes. Secretion rates were found to be higher in human islets compared to their murine counterpart. This method will be useful in understanding the roles of small molecules in biological systems.
Guidelines
Acknowledgements
We would like to thank Dr Xinsong Lin at Florida State University for his help with instrument maintenance, as well as Yao Wang and I-An Wei for their help with murine islet isolation. This research used resources provided by the Mass Spectrometry Laboratory at the FSU Department of Chemistry and Biochemistry (FSU075000MASS). This work was supported in part by grants from the National Institutes of Health, R01 DK080714, and using resources and/or funding provided by the NIDDK-supported Human Islet Research Network (HIRN, RRID: SCR_014393; https://hirnetwork.org; UC4 DK116283 to MGR).
References
CITATION
CITATION
CITATION
Materials
Chemicals and reagents:
Sodium hydroxide (NaOH)(Catalog# 72068)was purchased from EMD Millipore (San Diego, CA).
LC grade acetonitrile (ACN)(Catalog# 97065-022) was from VWR (Radnor, PA).
d4-Acetylcholine (d4-ACh)(Catalog# D-2558) was from CDN Isotopes Inc. (Pointe-Claire, QC).
All solutions were made with HPLC grade submicron filtered water(Catalog# W5SK-1) (Fisher Chemical, Fair Lawn, NJ).
Stock solutions of serine (Ser), threonine (Thr), asparagine (Asn), glutamine (Gln), alanine (Ala), histidine (His), aspartate (Asp), tyrosine (Tyr), γ-aminobutyric acid (GABA), valine (Val), methionine (Met), leucine (Leu), phenylalanine (Phe), tryptophan (Trp), arginine (Arg), taurine (Tau), glycine (Gly), glutamate (Glu), dopamine (DA), serotonin (5-HT), proline (Pro), trans-4-hydroxy proline (Hyp), cysteine (Cys), lysine (Lys), isoleucine (Ile), α-aminobutyric acid (α-ABA), β-aminobutyric acid (β-ABA), β-homoserine (β-HSer), tyramine (TryA), citrulline (Cit), kynurenine (Kyn), 2-aminoadipic acid (Aad), ornithine (Orn), histamine (Hist), 5-hydroxytryptophan (5-HTP), N-acetylcysteine (NAC), epinephrine (Epi), and acetylcholine (ACh) were made in LC water and diluted to working concentrations using a balanced salt solution (BSS) containing 25 mM tricine, 125 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl², 2.4 mM CaCl², and various glucose concentrations as described in the text, and the pH was adjusted to 7.4 with NaOH.
Safety warnings
Safety information
Acetonitrile (ACN)
Hazard statements:
Highly flammable liquid and vapor.
Harmful if swallowed, in contact with skin or if inhaled.
Causes serious eye irritation.
Precautionary statements:
Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Wear protective gloves/protective clothing/eye protection/face protection.
IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
IF exposed or concerned: Immediately call a POISON CENTER/doctor
Methods
Methods
Benzoyl chloride derivatization
For production of calibration curves, 100 µL of a standard mixture of small molecules (concentrations given in Section 3.3 in the original publication) in BSS was mixed with 50 µL of 100 mM sodium carbonate (9.2 ) and 50 µL 2% BzCl (by volume in ACN). The mixture was vortexed and allowed to react for 30 s before quenching with 50 µL of IS (composition described below). The ratio of sample : carbonate buffer : BzCl : IS was always 2 : 1 : 1 : 1 (v/v/v/v). IS were produced by derivatization of the small molecules with13C benzoyl chloride using the method described above. Because ACh did not derivatize, d4-ACh was spiked into the IS solution to a final concentration of 100 nM. To obtain desalted components for building the MRM method described in LC-MS instrumentation Section, analytes and IS were extracted with dichloromethane (DCM), followed by evaporation with N2 gas and reconstitution in 20% ACN containing 0.1% formic acid (FA).
LC-MS instrumentation
LC-MS experiments were performed using a Thermo Scientific (Waltham, MA) Vanquish Flex UHPLC system with a Split Sampler Module and a Thermo Scientific TSQ Quantis triple quadrupole mass spectrometer. 10 mM ammonium formate with 0.1% FA was used as mobile phase A (MPA) and ACN containing 0.1% FA used as mobile phase B (MPB). Separations were performed on a 2.1 × 150 mm, 2.7 μm, 160 Å pore ES-C18 column (Halo Peptide, Mac-Mod Analytical, Chadds Ford, PA) used with a 2.1 × 5 mm, 2.7 μm, 160 Å pore ES-C18 guard column (Mac-Mod Analytical). The injection volume was 5 μL and the mobile phase flow rate was 0.25 mL min−1. The column temperature was held constant at 25 °C in still air mode while the autosampler was set to 4 °C .
The TSQ Quantis mass spectrometer was operated in MRM mode. Electrospray settings were: spray voltage of 3500 V, sheath gas at 4.19 L min−1, auxiliary gas of 6.4 L min−1, sweep gas 1.5 L min−1, ion transfer tube temperature of 300 °C , and a capillary temperature of 275 °C . For MS/MS optimization, desalted sample was directly infused into the mass spectrometer at a flow rate of 50 μL min−1. The most intense and consistent fragments were used for building the MS/MS method for each analyte and IS. During LC-MS/MS runs, a time managed MRM was performed where the MRM transition for specific analytes were examined in a retention time (RT) window, defined as the RT ± 0.50 min (Table S-1). A dwell time of 50 ms was used for each transition.
Isolation and culture of islets of Langerhans
All animal experiments were performed under guidelines approved by the Florida State University Animal Care and Use Committee, protocol 202000078. Murine islets were obtained by digesting the pancreas from two male CD-1 mice (20–40 g) with collagenase as previously described1,2. The islets from both mice were combined and incubated at 37 °C with 5% CO2 in RPMI 1640(Cat# 10-040-CV, Corning, Manassas, VA) containing 11 mM glucose, l-glutamine, 10% fetal bovine serum, 100 U mL−1penicillin, 100 μg mL−1streptomycin, and 10 μg mL−1gentamycin. Islets were used the day after isolation.
Human islets were purchased from Prodo Laboratories (Aliso Viejo, CA) from donors with no history of diabetes. The islets were recovered according to the protocol established by Prodo Laboratories, followed by incubation in Prodo Islet Media Standard PIM(S) at 37 °C and 5% CO2 for at least 1 day. Human islet samples were from deidentified cadaveric organ donors and therefore exempt from Institutional Review Board approval. Islets from two donors were used in separate experiments and donor characteristics are shown in Table S-2. Islets from Donor 1 were used in a static incubation experiment while islets from Donor 2 were used in a perfusion experiment.
Static incubation of islets
For static incubation experiments, 20 human or murine islets were removed from culture media and rinsed three times with prewarmed BSS containing 1 or 3 mM glucose, respectively. The rinsed islets were then placed in a 250 μL microcentrifuge tube containing 100 μL of the same BSS solution and incubated at 37 °C with 5% CO2. After one hour, 90 μL of the supernatant was removed and replaced with 90 μL BSS containing 22.2 mM glucose for human islets and 22 mM glucose for murine islets to bring the final glucose concentration to 20 mM. The islets were then incubated for 1 h at 37 °C with 5% CO2, after which another 90 μL of the supernatant was removed. Supernatant from both incubations were derivatized separately as described in Benzoyl chloride derivatization Section.
Dynamic perfusion of islets
The microfluidic device fabrication, setup, and characterization are similar to that described elsewhere3 and given in more detail in the ESI.† Prior to each use of the microfluidic device, the system was conditioned by flowing RPMI media with serum for 30 min and stopping the flow for 30 min. This procedure was followed by 30 min of perfusion with BSS containing 1 or 3 mM glucose for human or murine islets, respectively. 25 islets were held in a dish containing 1 or 3 mM prewarmed glucose in BSS for 10 min in the incubator. The islets were then loaded into the islet chamber and allowed to settle to the bottom. The islet chamber was sealed with PCR film, placed in the incubator for 10 min, after which the input and output tubing were connected. BSS with 1 or 3 mM glucose was delivered to the islets at 5 μL min−1for 30 min prior to fraction collection. Islets were perfused with low glucose (1 or 3 mM) for 10 min, followed by high glucose (20 mM) for 30 min, and low glucose (1 or 3 mM) for another 10 min. The fractions were collected in a 96-well plate, derivatized, and injected into the LC-MS.
Data analysis
Chromatograms were analyzed using Xcalibur (Thermo Scientific) software. The software was used to integrate the peak area that coincided with the retention time window for each analyte and IS. Calibration curves were constructed by plotting the ratio of the average blank-subtracted analyte : IS peak area for 3 injections against the concentration of analyte injected. Error bars in all plots are equal to ±1 standard deviation (SD) unless otherwise noted. Linear least-squares were used to fit the data and the resulting regression equations were used to calculate the unknown concentrations of analytes from islet samples. LOD for each analyte were calculated using 3 times the SD of the blank peak area divided by the slope of each calibration curve. Comparison of sample means was performed using a paired two-tailed t-test, unless otherwise noted, with significance determined when p< 0.05. Resolution (Rs) between peaks was calculated using the difference in retention times and the average of the peak widths at baseline.